The Quinolones: History and Overview

DeepDyve requires Javascript to function. Please enable Javascript on your browser to continue.

NORRIS, SANDRA; MANDELL, GERALD L.

The Quinolones : 1-22 – Jan 1, 1988

Download PDF

NORRIS, SANDRA; MANDELL, GERALD L.

The Quinolones : 1-22 – Jan 1, 1988

Loading next page...

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Ciprofloxacin: An update on clinical experience

Arcieri
In vitro activity of newer quinolones against anaerobic bacteria

Auckenthaler
Emergence of ciprofloxacin-resistant Pseudomonas aeruginosa after combined therapy with ciprofloxacin and amikacin

Azadian
Activities of new quinolone derivatives against genital pathogens

Aznar
Nalidixic acid in infections of urinary tract

Barlow
Economic impact of oral ciprofloxacin: A pharmacist's perspective

Barriere
Cross-resistance among cinoxacin, ciprofloxacin, DJ-6783, enoxacin, nalidixic acid, norfloxacin and oxolinic acid after in vitro selection of resistant populations

Barry
Antibacterial activities of ciprofloxacin, norfloxacin, oxolinic acid, cinoxacin and nalidixic acid

Barry
Norfloxacin: pharmacokinetics in comparison with other quinolones

Bergan
Pharmacokinetics of ciprofloxacin and effect of repeated dosage on salivary and fecal microflora

Bergan
Pharmacokinetics of ciprofloxacin: Intravenous and increasing oral doses

Bergan
Influence of media and method on the in vitro susceptibility of Pseudomonas aeruginosa and other bacteria to ciprofloxacin and enoxacin

Blaser
Effect of inoculum, pH, and medium on the activity of ciprofloxacin against anaerobic bacteria

Borobio
Ciprofloxacin versus tobramycin plus azlocillin in pulmonary exacerbations in adult patients with cystic fibrosis

Bosso